Development of niosome-loaded bromelain as anti-inflammatory agent

Simple item page
dc.contributor.authorChermahini, Siavash Hosseinpour
dc.date.accessioned2024-06-22T10:35:35Z
dc.date.available2024-06-22T10:35:35Z
dc.date.issued2015
dc.descriptionThesis (PhD. (Bioprocess Engineering))
dc.description.abstractInflammation can be considered as common human being anxiousness. Nonsteroidal anti-inflammatory drugs (NSAIDS) are usually prescribed to reduce inflammation but they may lead to serious side-effects. Recently anti-inflammatory property of bromelain have been documented, but oral administration of bromelain requires higher concentration as compared to topical delivery. Hence, topical delivery of bromelain as a more favorable anti-inflammatory solution for skin inflammation, but it has to overcome stratum corneum (SC) skin barrier. The aims of this study were to design a bromelain delivery system based on niosome and to evaluate the efficacy of the bromelain-niosome system. Moreover, anti-inflammatory effect of niosome encapsulated bromelain was studied by Interleukin-6 (IL-6) and Tumor Necrotic Factor–alpha (TNF-a) response. This potential anti-inflammatory property of niosome encapsulated bromelain was investigated in-vitro and in-vivo, using human skin fibroblast cell line (HSF 1184) and mice, respectively. Lipopolysaccharide (LPS) was used in volume of 1.5 µg/mL in-vitro and 7.5 µg/mL in-vivo to induce inflammation. The current results showed that 20 µg/mL niosome encapsulated with 10% bromelain after four hours of post treatment significantly eliminated inflammation in HSF 1184 cell line as compared to non-encapsulated bromelain, vehicle (niosome), and controls. Similar result was achieved in mice where 20 mg niosome encapsulated with 10% bromelain was found able to eliminate inflammation after 30 minutes of post treatment. In conclusion, this research provides scientific evidence to show effective transdermal delivery of niosome encapsulated bromelain to reach targeted dermal cells and show its pharmaceutical potential to eliminate skin inflammation.
dc.description.sponsorshipFaculty of Chemical Engineering
dc.identifier.urihttp://openscience.utm.my/handle/123456789/1222
dc.language.isoen
dc.publisherUniversiti Teknologi Malaysia
dc.subjectAnti-Inflammatory Agents—analysis
dc.subjectBromelin
dc.subjectSkin—Inflammation
dc.titleDevelopment of niosome-loaded bromelain as anti-inflammatory agent
dc.typeThesis
dc.typeDataset
Files
Original bundle
Now showing 1 - 5 of 9
Thumbnail Image
Name:
SiavashHosseinpourChermahiniFChE2015_A.pdf
Size:
124.17 KB
Format:
Adobe Portable Document Format
Description:
IN-VITRO AND IN-VIVO TESTING BY USING CYTOKINE IL-6
Download
Thumbnail Image
Name:
SiavashHosseinpourChermahiniFChE2015_B.pdf
Size:
174.47 KB
Format:
Adobe Portable Document Format
Description:
IN-VITRO AND IN-VIVO TESTING BY USING CYTOKINE TNF-α
Download
Thumbnail Image
Name:
SiavashHosseinpourChermahiniFChE2015_C.pdf
Size:
117 KB
Format:
Adobe Portable Document Format
Description:
CALCULATION OF IN-VITRO AND IN-VIVO EFFECTIVE DOSING NIOSOME USING T-TEST (IL-6)
Download
Thumbnail Image
Name:
SiavashHosseinpourChermahiniFChE2015_D.pdf
Size:
159.06 KB
Format:
Adobe Portable Document Format
Description:
CALCULATION OF IN-VITRO AND IN-VIVO EFFECTIVE DOSING NIOSOME USING T-TEST (TNF-α)
Download
Thumbnail Image
Name:
SiavashHosseinpourChermahiniFChE2015_F.pdf
Size:
49.85 KB
Format:
Adobe Portable Document Format
Description:
MTT VALUE CELLS TREATED WITH NIOSOME ENCAPSULATED BROMELAIN AND BROMELAIN
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
Medical and Health Sciences